Remove Controlled Substances Remove Hospitals Remove Labelling
article thumbnail

Using My Medical Advocate Skills To Detect And Eliminate Errors With My Girlfriend’s Prescription

The Happy PharmD

I was a staff pharmacist working in my first hospital. I liked working as a staff pharmacist in a hospital. Most of them were written by residents in the hospital. I have been in hospital pharmacy management for over thirty years. As a hospital pharmacy manager, I have been in the medical field for over thirty years.

Dosage 52
article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

FDA Law Blog: Biosimilars

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. HHS forwards FDA’s analysis and recommendation to DEA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana

FDA Law Blog: Biosimilars

Houck — Last August Health and Human Services (“HHS”) recommended rescheduling marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed. By Larry K. 44,597 (May 21, 2024). 29, 2023) (“Basis”); NPRM at 44,603.

article thumbnail

Governors’ Push President on Cannabis Rescheduling But Overlook What Schedule III Would Require

FDA Law Blog: Biosimilars

They contended that access to cannabis is associated with reduced rates of: Opioid use and abuse; Opioid-related hospitalizations; Opioid-related traffic fatalities; Opioid-related drug treatment admissions; and Opioid-related overdose deaths.